Sodium acid pyrophosphate (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 166 | Pseudoxanthoma elasticum | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2018-001492-20-FI (EUCTR) | 20/06/2018 | 11/06/2018 | Pyrophosphate therapy in PXE disease | Pseudoxanthoma elasticum – supplementation therapy of pyrophosphate deficiency | Pseudoxanthoma elasticum;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] | Trade Name: SODIUM ACID PYROPHOSPHATE Product Name: SODIUM ACID PYROPHOSPHATE SAPP ROR 28 FOOD GRADE Product Code: CAS No.: 7758-16-9 | Tampere university hospital | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 100 | Phase 2;Phase 3 | Finland |